nodes	percent_of_prediction	percent_of_DWPC	metapath
Pralidoxime—BCHE—diaphragm—chronic obstructive pulmonary disease	0.156	0.692	CbGeAlD
Pralidoxime—Excitement—Aminophylline—chronic obstructive pulmonary disease	0.0771	0.0997	CcSEcCtD
Pralidoxime—Excitement—Salbutamol—chronic obstructive pulmonary disease	0.0554	0.0716	CcSEcCtD
Pralidoxime—Hyperventilation—Salbutamol—chronic obstructive pulmonary disease	0.0395	0.051	CcSEcCtD
Pralidoxime—Inflammation—Formoterol—chronic obstructive pulmonary disease	0.0297	0.0384	CcSEcCtD
Pralidoxime—Inflammation—Arformoterol—chronic obstructive pulmonary disease	0.0297	0.0384	CcSEcCtD
Pralidoxime—Inflammation—Salbutamol—chronic obstructive pulmonary disease	0.028	0.0362	CcSEcCtD
Pralidoxime—BCHE—respiratory system—chronic obstructive pulmonary disease	0.0178	0.079	CbGeAlD
Pralidoxime—Drowsiness—Montelukast—chronic obstructive pulmonary disease	0.0158	0.0204	CcSEcCtD
Pralidoxime—Drowsiness—Salbutamol—chronic obstructive pulmonary disease	0.0152	0.0196	CcSEcCtD
Pralidoxime—Agitation—Aminophylline—chronic obstructive pulmonary disease	0.0152	0.0196	CcSEcCtD
Pralidoxime—Vision blurred—Tiotropium—chronic obstructive pulmonary disease	0.0147	0.019	CcSEcCtD
Pralidoxime—BCHE—bronchus—chronic obstructive pulmonary disease	0.0147	0.065	CbGeAlD
Pralidoxime—BCHE—smooth muscle tissue—chronic obstructive pulmonary disease	0.0144	0.0636	CbGeAlD
Pralidoxime—Haemoglobin—Salbutamol—chronic obstructive pulmonary disease	0.0137	0.0177	CcSEcCtD
Pralidoxime—Haemorrhage—Salbutamol—chronic obstructive pulmonary disease	0.0137	0.0176	CcSEcCtD
Pralidoxime—Dizziness—Roflumilast—chronic obstructive pulmonary disease	0.0134	0.0173	CcSEcCtD
Pralidoxime—BCHE—trachea—chronic obstructive pulmonary disease	0.0132	0.0584	CbGeAlD
Pralidoxime—Tachycardia—Aminophylline—chronic obstructive pulmonary disease	0.0132	0.017	CcSEcCtD
Pralidoxime—Headache—Roflumilast—chronic obstructive pulmonary disease	0.0127	0.0164	CcSEcCtD
Pralidoxime—Tachycardia—Tiotropium—chronic obstructive pulmonary disease	0.0124	0.0161	CcSEcCtD
Pralidoxime—Nausea—Roflumilast—chronic obstructive pulmonary disease	0.012	0.0155	CcSEcCtD
Pralidoxime—Agitation—Arformoterol—chronic obstructive pulmonary disease	0.0116	0.0149	CcSEcCtD
Pralidoxime—Agitation—Formoterol—chronic obstructive pulmonary disease	0.0116	0.0149	CcSEcCtD
Pralidoxime—Agitation—Montelukast—chronic obstructive pulmonary disease	0.0113	0.0146	CcSEcCtD
Pralidoxime—Agitation—Salbutamol—chronic obstructive pulmonary disease	0.0109	0.0141	CcSEcCtD
Pralidoxime—Tachycardia—Arformoterol—chronic obstructive pulmonary disease	0.01	0.013	CcSEcCtD
Pralidoxime—Tachycardia—Formoterol—chronic obstructive pulmonary disease	0.01	0.013	CcSEcCtD
Pralidoxime—Muscular weakness—Prednisolone—chronic obstructive pulmonary disease	0.00998	0.0129	CcSEcCtD
Pralidoxime—BCHE—lung—chronic obstructive pulmonary disease	0.00948	0.0419	CbGeAlD
Pralidoxime—Tachycardia—Salbutamol—chronic obstructive pulmonary disease	0.00947	0.0122	CcSEcCtD
Pralidoxime—Somnolence—Formoterol—chronic obstructive pulmonary disease	0.00913	0.0118	CcSEcCtD
Pralidoxime—Somnolence—Arformoterol—chronic obstructive pulmonary disease	0.00913	0.0118	CcSEcCtD
Pralidoxime—Somnolence—Montelukast—chronic obstructive pulmonary disease	0.00895	0.0116	CcSEcCtD
Pralidoxime—Dizziness—Aminophylline—chronic obstructive pulmonary disease	0.00893	0.0115	CcSEcCtD
Pralidoxime—Pain—Arformoterol—chronic obstructive pulmonary disease	0.00879	0.0113	CcSEcCtD
Pralidoxime—Pain—Formoterol—chronic obstructive pulmonary disease	0.00879	0.0113	CcSEcCtD
Pralidoxime—Somnolence—Salbutamol—chronic obstructive pulmonary disease	0.00862	0.0111	CcSEcCtD
Pralidoxime—Pain—Montelukast—chronic obstructive pulmonary disease	0.00861	0.0111	CcSEcCtD
Pralidoxime—Headache—Aminophylline—chronic obstructive pulmonary disease	0.00846	0.0109	CcSEcCtD
Pralidoxime—Dizziness—Tiotropium—chronic obstructive pulmonary disease	0.00842	0.0109	CcSEcCtD
Pralidoxime—Pain—Salbutamol—chronic obstructive pulmonary disease	0.0083	0.0107	CcSEcCtD
Pralidoxime—Nausea—Aminophylline—chronic obstructive pulmonary disease	0.00802	0.0104	CcSEcCtD
Pralidoxime—Headache—Tiotropium—chronic obstructive pulmonary disease	0.00797	0.0103	CcSEcCtD
Pralidoxime—Haemoglobin—Prednisolone—chronic obstructive pulmonary disease	0.00787	0.0102	CcSEcCtD
Pralidoxime—Haemorrhage—Prednisolone—chronic obstructive pulmonary disease	0.00783	0.0101	CcSEcCtD
Pralidoxime—Nausea—Tiotropium—chronic obstructive pulmonary disease	0.00756	0.00977	CcSEcCtD
Pralidoxime—Muscular weakness—Prednisone—chronic obstructive pulmonary disease	0.00726	0.00937	CcSEcCtD
Pralidoxime—Dizziness—Formoterol—chronic obstructive pulmonary disease	0.00679	0.00878	CcSEcCtD
Pralidoxime—Dizziness—Arformoterol—chronic obstructive pulmonary disease	0.00679	0.00878	CcSEcCtD
Pralidoxime—Dizziness—Montelukast—chronic obstructive pulmonary disease	0.00665	0.0086	CcSEcCtD
Pralidoxime—Headache—Formoterol—chronic obstructive pulmonary disease	0.00644	0.00831	CcSEcCtD
Pralidoxime—Headache—Arformoterol—chronic obstructive pulmonary disease	0.00644	0.00831	CcSEcCtD
Pralidoxime—Vision blurred—Prednisolone—chronic obstructive pulmonary disease	0.00642	0.0083	CcSEcCtD
Pralidoxime—Dizziness—Salbutamol—chronic obstructive pulmonary disease	0.00641	0.00829	CcSEcCtD
Pralidoxime—Headache—Montelukast—chronic obstructive pulmonary disease	0.0063	0.00814	CcSEcCtD
Pralidoxime—Nausea—Formoterol—chronic obstructive pulmonary disease	0.0061	0.00788	CcSEcCtD
Pralidoxime—Nausea—Arformoterol—chronic obstructive pulmonary disease	0.0061	0.00788	CcSEcCtD
Pralidoxime—Headache—Salbutamol—chronic obstructive pulmonary disease	0.00608	0.00785	CcSEcCtD
Pralidoxime—Nausea—Montelukast—chronic obstructive pulmonary disease	0.00598	0.00772	CcSEcCtD
Pralidoxime—Nausea—Salbutamol—chronic obstructive pulmonary disease	0.00576	0.00744	CcSEcCtD
Pralidoxime—Haemoglobin—Prednisone—chronic obstructive pulmonary disease	0.00572	0.00739	CcSEcCtD
Pralidoxime—Haemorrhage—Prednisone—chronic obstructive pulmonary disease	0.00569	0.00735	CcSEcCtD
Pralidoxime—Tachycardia—Prednisolone—chronic obstructive pulmonary disease	0.00543	0.00702	CcSEcCtD
Pralidoxime—Pain—Prednisolone—chronic obstructive pulmonary disease	0.00476	0.00615	CcSEcCtD
Pralidoxime—Vision blurred—Prednisone—chronic obstructive pulmonary disease	0.00467	0.00603	CcSEcCtD
Pralidoxime—Agitation—Prednisone—chronic obstructive pulmonary disease	0.00455	0.00588	CcSEcCtD
Pralidoxime—Tachycardia—Prednisone—chronic obstructive pulmonary disease	0.00395	0.0051	CcSEcCtD
Pralidoxime—Dizziness—Prednisolone—chronic obstructive pulmonary disease	0.00368	0.00475	CcSEcCtD
Pralidoxime—Headache—Prednisolone—chronic obstructive pulmonary disease	0.00349	0.0045	CcSEcCtD
Pralidoxime—Nausea—Prednisolone—chronic obstructive pulmonary disease	0.0033	0.00427	CcSEcCtD
Pralidoxime—Dizziness—Prednisone—chronic obstructive pulmonary disease	0.00267	0.00345	CcSEcCtD
Pralidoxime—Headache—Prednisone—chronic obstructive pulmonary disease	0.00253	0.00327	CcSEcCtD
Pralidoxime—Nausea—Prednisone—chronic obstructive pulmonary disease	0.0024	0.0031	CcSEcCtD
